BioMarin Pharmaceutical Inc. <BMRN.O>: H.C. Wainwright Raises Target Price to $60 From $59
BMRN•Related News
Ascendis Pharma A/S <ASND.O>: H.C. Wainwright cuts target price to $344 from $345
ASND•
US Stocks-Wall St dips as rising oil prices, hawkish Fed bets pressure stocks
SPY•
Hyatt opens 467-room adults-only Hyatt Vivid Punta Cana all-inclusive resort in Dominican Republic
H•
Horizon Kinetics Asset Management acquires Texas Pacific Land shares worth $364.42
TPL•
Goldman Sachs CEO David Solomon On US Economy Says The Consumer Is Still Pretty Resilient - CNBC Interview
GS•